LRRC37A4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.580400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.232600E-01
Normal-vs-Stage2
4.519800E-01
Normal-vs-Stage3
2.720800E-01
Normal-vs-Stage4
4.172600E-01
Stage1-vs-Stage2
7.416800E-01
Stage1-vs-Stage3
1.605990E-01
Stage1-vs-Stage4
6.370800E-01
Stage2-vs-Stage3
9.528400E-02
Stage2-vs-Stage4
7.789600E-01
Stage3-vs-Stage4
1.302560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.593400E-01
Normal-vs-AfricanAmerican
5.394800E-01
Normal-vs-Asian
4.073000E-01
Caucasian-vs-AfricanAmerican
6.459000E-01
Caucasian-vs-Asian
5.497600E-01
AfricanAmerican-vs-Asian
3.715400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.333200E-01
Normal-vs-Female
1.269600E-01
Male-vs-Female
2.512800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.032800E-01
Normal-vs-Age(41-60Yrs)
5.222400E-01
Normal-vs-Age(61-80Yrs)
4.429800E-01
Normal-vs-Age(81-100Yrs)
3.839600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.103200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.738800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.484200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.867960E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.387400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.047200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.967000E-01
Normal-vs-Daily Drinker
3.647400E-01
Normal-vs-Weekly Drinker
4.382800E-01
Normal-vs-Occasional Drinker
3.789600E-01
Normal-vs-Social Drinker
4.810400E-01
Non Drinker-vs-Daily Drinker
6.100600E-01
Non Drinker-vs-Weekly Drinker
6.552400E-01
Non Drinker-vs-Occasional Drinker
2.816400E-01
Non Drinker-vs-Social Drinker
4.085700E-02
Daily Drinker-vs-Weekly Drinker
2.941400E-01
Daily Drinker-vs-Occasional Drinker
1.625560E-01
Daily Drinker-vs-Social Drinker
2.825700E-02
Weekly Drinker-vs-Occasional Drinker
4.667400E-01
Weekly Drinker-vs-Social Drinker
1.519390E-01
Occasional Drinker-vs-Social Drinker
5.903600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.348400E-01
Normal-vs-Grade 2
8.100000E-02
Normal-vs-Grade 3
3.341700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.712000E-01
Grade 1-vs-Grade 3
6.959200E-01
Grade 1-vs-Grade 4
2.348400E-01
Grade 2-vs-Grade 3
5.355200E-01
Grade 2-vs-Grade 4
8.100000E-02
Grade 3-vs-Grade 4
3.341700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.033800E-01
Normal-vs-NonDiabetic
4.571000E-01
Diabetic-vs-NonDiabetic
2.544000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.070000E-01
Normal-vs-NoPancreatitis
4.462800E-01
Pancreatitis-vs-NoPancreatitis
6.497800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.918620E-01
Normal-vs-N1
4.526600E-01
N0-vs-N1
7.807800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.327800E-01
Normal-vs-TP53-NonMutant
3.418400E-01
TP53-Mutant-vs-TP53-NonMutant
4.707800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
